Results 161 to 170 of about 53,590 (235)

In vitro drug resistance profiles of adult versus childhood acute lymphoblastic leukaemia [PDF]

, 2000
Huismans, D.R. (D.), Pieters, R. (Rob), Schuurhuis, G.J. (Gerrit Jan), Styczynski, J. (Jan), Veerman, A.J.P. (Anjo), Wysocki, M. (Mariusz)   +5 more
core   +4 more sources

Comparative pharmacoinformatic and quantum descriptor insights from BFM/GBTLI guidelines to phase I/II compounds for acute lymphoblastic leukemia (ALL). [PDF]

Sci Rep
Bahia IAF, da Silva MK, Sindi ER, Rodrigues-Neto JF, da Silva ED, Alqahtani T, Tiruneh YK, Zaki MEA, Fulco UL, Oliveira JIN.   +9 more
europepmc   +1 more source

Co-culture shock. [PDF]

Cell Death Discov
Behan JW, Mittelman SD.
europepmc   +1 more source

Drug strategies for the treatment and prevention of proliferative vitreoretinopathy: an overview of innovative treatment concepts. [PDF]

Int Ophthalmol
Luyken AK, Junge V, Schulz A, Fuchsluger TA, Schaub F.   +4 more
europepmc   +1 more source

CPX-351 vs daunorubicin, cytarabine, and gemtuzumab ozogamicin in older adults with non-adverse-risk AML: the NCRI AML18 trial.

Blood
Knapper S, Dillon LW, Babu M, Thomas A, Thomas I, Hourigan CS, Andrew G, Dillon R, Gilkes A, Marquez Almuina N, King S, McCarthy N, Bahr R, Al-Ali RW, Stone L, Coats T, Byrne J, Green S, Overgaard UM, Sellar RS, Dennis M, Mehta P, Hills R, Freeman SD, Russell NH.   +24 more
europepmc   +1 more source

Studying clonal heterogeneity of acute myeloid leukemia under nutrient and chemotherapy stress. [PDF]

Blood Adv
Mayerhofer C, Crompton E, Mayerhofer E, Kristiansen T, Fukushima T, Keyes S, Sharda A, Li D, Da Silva C, Shrestha D, Kiem A, Feuchtinger T, Scadden DT, Miller PG.   +13 more
europepmc   +1 more source

Chronopharmacology of mitoxantrone (MX): Evodence for a circadian rhythm of its myelotoxicity from an animal model and a clinical pilot trial [PDF]

, 1993
Emmerich, B., Hallek, M., Kammermeier, I., Langenmayer, Irmgard, Levi, F.   +4 more
core  

Necrotizing soft tissue infection of the fingertips secondary to paronychia in a leukemic child: a case report and warning. [PDF]

Front Pediatr
Li N, Zhang Z, Lu Y, Wu H, Zhang Y, Cong F.   +5 more
europepmc   +1 more source

Mathematical modeling and statistical analysis of breast cancer drugs using M-polynomial indices for the physical properties. [PDF]

Sci Rep
Tawhari QM, Naeem M, Maqbool S, Rauf A, Oyelakin O.   +4 more
europepmc   +1 more source

QSPR analysis of anticancer drugs using the Euler-Sombor index and theoretical insights on its minimum value for unicyclic graphs. [PDF]

Sci Rep
Shetty S, Rakshith BR, Udupa NVS.
europepmc   +1 more source